Skip to main content

Jobs Job Match Companies People Locations Salaries Blog Resume Scanner Post a Job

Zero G Talent

Jobs
Job Match
Companies
People
Locations
Salaries
Blog
Resume Scanner
Post a Job

About
Contact
Privacy
Terms

© 2026 Zero G Talent. All rights reserved.

Home
People
David Pompliano

David Pompliano

David Pompliano

Principal & Owner, Sanderling Consulting

Co-Founder and Chief Innovation Officer at Odyssey Therapeutics

New York, New York

About

Male

David L. Pompliano is the Co-Founder and Chief Innovation Officer at Odyssey Therapeutics. He attended Harvard University.

Experience

Odyssey Therapeutics

Co-Founder and Chief Innovation Officer

Growth118Boston, Massachusetts, United StatesBiotech/Pharma · Biotechnology

Operating Partner · Accelerator Life Science Partners
2016 – present
Principal & Owner · Sanderling Consulting
2008 – present

Education

Stanford University · Ph.D., Chemistry
– 1987
University of Virginia · B.S., Chemistry
– 1982
Stanford University · Ph.D, unknown

People at Odyssey Therapeutics

Board of Directors

Executive Vice President and Head of Cancer Biology

Data from: crunchbase

Christopher Butler

Senior Vice President, Head of Chemistry

EVP of Non-Clinical Development

Executive Vice President and Head of Non-Clinical Development

View all at Odyssey Therapeutics →

Latest from David Pompliano

Headlines from Google News. Social posts load from the platform only when you open a tab.

Infinant Health Appoints New Team Members to assist with Drug Development
Nasdaq · May 22
Catalio Capital Management Joins $168 Million Series B for Odyssey Therapeutics
citybiz · Oct 14
Serial entrepreneur, former IFM CEO launches immuno-oncology startup
The Business Journals · Dec 7
Top 100 Massachusetts Startups to Watch in 2026
Failory · Aug 12
Top 93 Cambridge Startups to Watch in 2026
Failory · Aug 11